Danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, will undergo dose optimization studies in the second half of 2024 as Pfizer seeks to evaluate multiple doses of the formulation which they hope will inform the registration-enabling studies
Built for Oilfield Rotations Whether you're 14-on/7-off, on a drilling rig, or in an executive office at a major operator telehealth fits any rotation schedule
Retatrutide reaches for all three, and that third lever, the glucagon receptor, is the part that nudges your body to burn a little more energy rather than only eating less
Rosemary Daly, D.O., DABPM, is a board-certified interventional pain specialist with over 20 years of experience serving South Florida
Safety and tolerability of high doses of the long acting, human GLP-1 analogue R1583 in diabetic subjects treated with metformin: a double-blind, placebocontrolled phase 2 study
Compound Purity and Stability: This is where the quality of your research materials becomes paramount